Maetzold Derek J's Form 4 filing
Castle Biosciences Inc (CSTL) · filed Apr 14, 2023
- Accession no.
- 0001447362-23-000060
- Filed
- Apr 14, 2023
- Trade date
- Apr 12-13, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 14 non-derivative transactions. Open-market sales total $189.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Maetzold Derek JCIK 0001239501 | Director, Officer (Pres. & Chief Exec. Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 12, 2023 | Common Stock | SSaleDisposed | −969 | $22.61F2 | −$21,909.09 | 156,596 | Direct | |
| Apr 12, 2023 | Common Stock | SSaleDisposed | −484 | $22.61F2 | −$10,943.24 | 115,862 | Indirect | |
| Apr 12, 2023 | Common Stock | SSaleDisposed | −484 | $22.61F2 | −$10,943.24 | 104,757 | Indirect | |
| Apr 12, 2023 | Common Stock | SSaleDisposed | −242 | $22.61F2 | −$5,471.62 | 21,370 | Indirect | |
| Apr 12, 2023 | Common Stock | SSaleDisposed | −242 | $22.61F2 | −$5,471.62 | 21,371 | Indirect | |
| Apr 12, 2023 | Common Stock | SSaleDisposed | −242 | $22.61F2 | −$5,471.62 | 21,370 | Indirect | |
| Apr 12, 2023 | Common Stock | SSaleDisposed | −242 | $22.61F2 | −$5,471.62 | 21,363 | Indirect | |
| Apr 13, 2023 | Common Stock | SSaleDisposed | −1,823 | $22.68F9 | −$41,345.64 | 154,773 | Direct | |
| Apr 13, 2023 | Common Stock | SSaleDisposed | −912 | $22.68F9 | −$20,684.16 | 114,950 | Indirect | |
| Apr 13, 2023 | Common Stock | SSaleDisposed | −912 | $22.68F9 | −$20,684.16 | 103,845 | Indirect | |
| Apr 13, 2023 | Common Stock | SSaleDisposed | −455 | $22.68F9 | −$10,319.4 | 20,915 | Indirect | |
| Apr 13, 2023 | Common Stock | SSaleDisposed | −455 | $22.68F9 | −$10,319.4 | 20,916 | Indirect | |
| Apr 13, 2023 | Common Stock | SSaleDisposed | −455 | $22.68F9 | −$10,319.4 | 20,915 | Indirect | |
| Apr 13, 2023 | Common Stock | SSaleDisposed | −455 | $22.68F9 | −$10,319.4 | 20,908 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $22.450 to $22.980, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 7 transactions in Table I.
- F9
This transaction was executed in multiple trades at prices ranging from $22.385 to $23.040, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 7 transactions in Table I.